Loading...

Genetron Holdings Limited

GTHNASDAQ
Healthcare
Medical - Diagnostics & Research
$4.03
$0.005(0.12%)

Genetron Holdings Limited (GTH) Stock Overview

Explore Genetron Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.1/100

Key Financials

Market Cap127.3M
P/E Ratio-3.03
EPS (TTM)$-3.62
ROE-1.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$1.14

GTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genetron Holdings Limited (GTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.03 and a market capitalization of 127.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;